Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: A randomized controlled trial

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 8, 2011, Pages 1015-1021

  Mahmoud, K M ^a   Ammar, A S ^a  

^a Minoufiya Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATINE KINASE MB; INTERLEUKIN 1BETA; MALONALDEHYDE; PLACEBO; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; ANTIOXIDANT ACTIVITY; AORTA CLAMPING; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INFUSION; FEMALE; HEART INJURY; HEART PROTECTION; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; ADRENERGIC BETA-ANTAGONISTS; AGED; AORTIC ANEURYSM, ABDOMINAL; BISOPROLOL; BLOOD PRESSURE; BODY MASS INDEX; CARDIAC SURGICAL PROCEDURES; CREATINE KINASE, MB FORM; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HEART FUNCTION TESTS; HEART INJURIES; HEART RATE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; TROPONIN I;

EID: 80052294229     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02492.x     Document Type: Article

References (26)

1. Diehl JT, Cali RF, Hertzer NR, Beven EG,. Complications of abdominal aortic reconstruction. An analysis of perioperative risk factors in 557 patients. Ann Surg 1983; 197: 49-56. (Pubitemid 13211723)
2. Cunningham AJ,. Anaesthesia for abdominal aortic surgery a review (Part 11). Can J Anaesth 1989; 36: 568-77. (Pubitemid 19233828)
3. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB,. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78: 651-5.
4. Raijmakers PG, Groeneveld AB, Rauwerda JA, Schneider AJ, Teule GJ, Hack CE, Thijs LG,. Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med 1995; 151: 698-705.
5. Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner H, Drenger B, Hasin Y, Berlatzky Y, Weissman C,. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 2001; 37: 1839-45. (Pubitemid 32499968)
6. Kim LJ, Martinez EA, Faraday N, Dorman T, Fleisher LA, Perler BA, Williams GM, Chan D, Pronovost PJ,. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 2002; 106: 2366-71. (Pubitemid 35244739)
7. Haggart PC, Adam DJ, Ludman PF, Bradbury AW,. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery. Br J Surg 2001; 88: 1196-200. (Pubitemid 34015603)
8. Abraham N, Lemech L, Sandroussi C, Sullivan D, May J,. A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms. J Vasc Surg 2005; 41: 377-80. (Pubitemid 40523574)
9. Meyer M, LeWinter MM, Bell SP, Chen Z, Selby DE, Singla DK, Dauerman HL,. N- acetylcysteine enhanced contrast provides cardiorenal protection. JACC Cardiovasc Interv 2009; 2: 215-21.
10. Sochman J, Vrbska J, Musilova B, Rocek M,. Infarct Size Limitation: Acute N-acetylcysteine Defense (ISLAND trial): preliminary analysis and report after the first 30 patients. Clin Cardiol 1996; 19: 94-100. (Pubitemid 26317711)
11. Aruoma OI, Halliwell B, Hoey BM, Butler J,. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-7. (Pubitemid 19147809)
12. Betts WH, Zhang Y, Rokicinski M, Horowitz JD,. N-acetylcysteine and captopril inhibit but S-nitroso-N-acetylcysteine stimulates human neutrophil free radical production. Circulation 1993; 88: I-90.
13. Forman MB, Puett DW, Cates CU, McCroskey DE, Beckman JK, Greene HL, Virmani R,. Glutathione redox pathway and reperfusion injury: effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1988; 78: 202-13.
14. Yesilbursa D, Serdar A, Senturk T, Serdar Z, Saǧ S, Cordan J,. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. Heart Vessels 2006; 21: 33-7. (Pubitemid 43174288)
15. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD,. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction, safety and biochemical effects. Circulation 1995; 92: 2855-62.
16. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr,. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987; 33: 214-20. (Pubitemid 17161121)
17. Whitehead TP, Thorpe GHG, Maxwell SRJ,. Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992; 266: 265-77.
18. Sochman J, Kolc J, Vrana M, Fabian J,. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 1990; 28: 191-6. (Pubitemid 20216837)
19. Ceconi C, Curello S, Cargnoni A, Ferrari R, Albertini A, Visioli O,. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetylcysteine. J Mol Cell Cardiol 1988; 20: 5-13.
20. Tripathi Y, Hegde BM,. Effect of N-acetylcysteine on myocardial infarct size following ischemia and reperfusion in dogs. Indian J Physiol Pharmacol 1998; 42: 50-6. (Pubitemid 28293355)
21. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, Suedkamp M, Kasper SM, Hellmich M, Mehlhorn U,. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2003; 126: 1513-20. (Pubitemid 37449181)
22. Menasché P, Grousset C, Gauduel Y, Mouas C, Piwnica A,. Maintenance of the myocardial thiol pool by N-acetylcysteine: an effective means of improving cardioplegic protection. J Thorac Cardiovasc Surg 1992; 103: 936-43.
23. Fischer UM, Cox CS Jr, Allen SJ, Stewart RH, Mehlhorn U, Laine GA,. The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. J Thorac Cardiovasc Surg 2003; 126: 1483-8. (Pubitemid 37449177)
24. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP,. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007; 133: 7-12. (Pubitemid 46014198)
25. Wang G, Bainbridge D, Martin J, Cheng D,. N-acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal. J Cardiothorac Vasc Anesth 2010; 25: 268-75.
26. Bergstroem L, Kagedal B, Paulsen O,. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 1986; 31: 217-22. (Pubitemid 17014593)